Why is the zebrafish model useful in studying neuropathological diseases?
Several models for studying neuropathological diseases exist, including mice, rats, zebrafish, Drosophila, C. elegans, and neuronal cell culture. The zebrafish model has become an essential tool for studying neuropathological processes and diseases due to its genetic resemblance to humans, as well as its similar neuroanatomical and neurochemical pathways.
Furthermore, general characteristics such as its rapid embryonic development, transparent larval stages allowing for efficient in vivo imaging, streamlined genetic manipulation, and utility for drug screening also make it a useful experimental model. Recent reviews highlight the utility of zebrafish models and their beneficial characteristics to study neuropathological processes7, 8.
Recently, Dulski et al.(9) investigated the role of Rac1 in brain connectivity impairments in a tuberous sclerosis complex (TSC) neurodevelopmental zebrafish model. Interestingly, they utilized both FRET and Rac1 G-LISA tools to analyze Rac1 activity in zebrafish larvae.
The FRET probe allowed investigators to measure live cell changes in Rac1 activity in the zebrafish brain. Complementary studies using the Rac1 G-LISA kit supported the FRET studies, while also enabling investigators to analyze the effects of Rac1 inhibitors in their model due to the faster processing time with this tool (see Figure 1).
The G-LISA data, in particular, was very promising as it's one of the first examples where this tool was used to analyze Rac1activity in zebrafish larvae9. When added to other examples where the Rac1 G-LISA was used to analyze Rac1 activity in mouse brain tissue10, 11 and neural progenitor cells12, it suggests that it may be an essential tool for neurobiologists studying Rac1.
References
1. Ma, N., et al., Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. Molecules, 2023. 28(7).
2. Wang, W., et al., Roles of Rac1-Dependent Intrinsic Forgetting in Memory-Related Brain Disorders: Demon or Angel. Int J Mol Sci, 2023. 24(13).
3. Marei, H. and A. Malliri, Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms. Small GTPases, 2017. 8(3): p. 139-163.
4. Kim, J., et al., Presynaptic Rac1 in the hippocampus selectively regulates working memory. Elife, 2024. 13.
5. Socodato, R., et al., Microglial Rac1 is essential for experience-dependent brain plasticity and cognitive performance. Cell Rep, 2023. 42(12): p. 113447.
6. Morstein, J., et al., Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket. Cell, 2024. 187(22): p. 6379-6392 e17.
7. Chia, K., et al., Zebrafish as a model organism for neurodegenerative disease. Front Mol Neurosci, 2022. 15: p. 940484.
8. Chauhan, A., et al., Zebrafish models for neurological disorders: a platform for natural product-based drug discovery. Frontiers in Natural Products, 2026. Volume 4 - 2025.
9. Dulski, T., O. Doszyń, and J. Zmorzyńska, Rac1 contributes to brain connectivity impairments and neuropsychiatric disorders in Tuberous Sclerosis Complex. bioRxiv, 2025: p. 2025.12.09.693152.
10. Haq, N., et al., Loss of Bardet-Biedl syndrome proteins causes synaptic aberrations in principal neurons. PLoS Biol, 2019. 17(9): p. e3000414.
11. Ishchenko, Y., et al., Heterozygosity for neurodevelopmental disorder-associated TRIO variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice. Elife, 2025. 13.
12. Wegscheid, M.L., et al., Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis. Cell Rep, 2021. 36(1): p. 109315.